ARYN DEL VALLE: Open Payments
NPI 1104475235 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,399 in 77 payments from 24 companies in 2025. Trend: 2023 $1,518 · 2024 $1,396 · 2025 $1,399
Food & beverage: $1,384Speaker / faculty: $15
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $369 |
| PFIZER INC. | 12 | $202 |
| SK Life Science, Inc. | 3 | $90 |
| Lilly USA, LLC | 4 | $80 |
| JAZZ PHARMACEUTICALS INC. | 3 | $77 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Octapharma USA, Inc. | 2 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Lundbeck LLC | 2 | $39 |
Products named: QULIPTA, NURTEC ODT, KESIMPTA, KISUNLA, VYALEV, XYWAV, PANZYGA, HYQVIA.
Industry payments across FL — which companies pay providers there.
